User fees: harsh treatment of small, foreign firms exposed
This article was originally published in Clinica
Executive Summary
A Republican Senator is challenging the US FDA's legal authority to charge all manufacturers the same fee to file a premarket notification in fiscal year 2003, no matter how large the company.